publication date: May. 8, 2015

Gunsalus: Duke’s 4.5 Years is at the Extreme End of the Spectrum For a Misconduct Probe


The Cancer Letter invited C. K. Gunsalus, an expert on scientific misconduct, to discuss the settlement of the lawsuits against Duke.

Gunsalus is the director of the National Center for Professional and Research Ethics, research professor, Coordinated Science Laboratory, professor emerita, College of Business at the University of Illinois at Urbana-Champaign. She runs a consulting company and is the author of The Young Professional’s Survival Guide (Harvard University Press, 2012) and The College Administrator’s Survival Guide (Harvard University Press, 2006).

Her guest editorial on the Duke genomics scandal appeared in the Jan. 23 issue of The Cancer Letter.

She spoke with Paul Goldberg, editor and publisher of The Cancer Letter.

Paul Goldberg: With the patients’ case settled, is Duke out of jeopardy?

C. K. Gunsalus: It depends on what you mean by “out of jeopardy.”

Settling all current lawsuits closes one front of Duke’s ongoing problems with one set of individuals.

I do not know if the settlement resolves the legal situation for all possible trial participants’ families. That is, do the settlements resolve the lawsuits filed to date or all possible trial-related litigation? Are there other potential lawsuits still within a statute of limitations? If other potential lawsuits are still possible, these settlements could set a pattern for future payments.

Continue reading 41-18 Gunsalus: Duke’s 4.5 Years is at the Extreme End of the Spectrum For a Misconduct Probe

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.